Remote Evaluation of MIND Diet
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-64
SponsorUniversity of Illinois at Urbana-Champaign
About this trial
The goal of this clinical trial is to learn if increasing adherence to a Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet pattern improves thinking ability and memory compared to a healthy control diet in persons with Multiple Sclerosis (MS). The main question it aims to answer is:
Does the MIND diet improve cognitive performance relative to a control diet in persons with MS?
Participants will:
Consume one meal that follows the MIND diet or a control meal every day for 3 months, complete online surveys and cognitive testing before and after, and keep a record of the food they eat during the study.
Eligibility criteria
Qualifiers
Individuals aged 18-64 years old
Self-reported diagnosis of Multiple sclerosis (MS)
20/20 or corrected vision
No other neurodegenerative disease diagnosis
Disqualifiers
Individuals younger than 18 or older than 64 years old
No self-reported diagnosis of Multiple sclerosis (MS)
Not 20/20 or uncorrected vision
Other neurodegenerative disease diagnosis
Trial design
Treatments tested in this trial
- MIND Diet
- Control Diet
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov